These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20020587)

  • 1. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
    Guran T; Turan S; Bircan R; Bereket A
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis of thyroid hormone resistance.
    Asteria C; Rajanayagam O; Collingwood TN; Persani L; Romoli R; Mannavola D; Zamperini P; Buzi F; Ciralli F; Chatterjee VK; Beck-Peccoz P
    J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
    Radetti G; Persani L; Molinaro G; Mannavola D; Cortelazzi D; Chatterjee VK; Beck-Peccoz P
    Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
    Anzai R; Adachi M; Sho N; Muroya K; Asakura Y; Onigata K
    Thyroid; 2012 Oct; 22(10):1069-75. PubMed ID: 22947347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
    Ueda S; Takamatsu J; Fukata S; Tanaka K; Shimizu N; Sakata S; Yamaji T; Kuma K; Ohsawa N
    Thyroid; 1996 Dec; 6(6):563-70. PubMed ID: 9001190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.
    Mannavola D; Vannucchi G; Fugazzola L; Cerutti N; Persani L; Beck-Peccoz P
    J Endocrinol Invest; 2002 Feb; 25(2):RC4-6. PubMed ID: 11929097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
    Mechelany C; Schlumberger M; Challeton C; Comoy E; Parmentier C
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
    Darendeliler F; Baş F
    J Pediatr Endocrinol Metab; 1997; 10(5):535-8. PubMed ID: 9401912
    [No Abstract]   [Full Text] [Related]  

  • 9. Pituitary resistance to thyroid hormone caused by a novel mutation (H435A) in the thyroid hormone receptor beta: A case report.
    Yu C; Zhao J; Yao J; Wang H; Shang H; Zhang R; Cui Y; Wang L; Dong J; Liao L
    Medicine (Baltimore); 2018 May; 97(21):e10544. PubMed ID: 29794730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone.
    Dulgeroff AJ; Geffner ME; Koyal SN; Wong M; Hershman JM
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1071-5. PubMed ID: 1400873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
    Bracco D; Morin O; Schutz Y; Liang H; Jéquier E; Burger AG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):221-8. PubMed ID: 8325946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up.
    Hamon B; Hamon P; Bovier-Lapierre M; Pugeat M; Savagner F; Rodien P; Orgiazzi J
    Thyroid; 2008 Jan; 18(1):35-44. PubMed ID: 18302516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting effects of Triac and thyroxine on the control of thyrotropin and hepatic deiodinase type I.
    Juge-Aubry CE; Morin O; Pernin AT; Liang H; Philippe J; Burger AG
    Eur J Endocrinol; 1995 Jun; 132(6):751-8. PubMed ID: 7788017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between an R338L mutation in the thyroid hormone receptor-beta gene and thyrotoxic features in two unrelated kindreds with resistance to thyroid hormone.
    Menzaghi C; Balsamo A; Di Paola R; Gallone G; Rossi C; Tassi V; Fonzo D; De Filippis V
    Thyroid; 1999 Jan; 9(1):1-6. PubMed ID: 10037068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy.
    Pohlenz J; Knöbl D
    Acta Paediatr; 1996 Mar; 85(3):387-90. PubMed ID: 8696005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperthyroidism caused by inadequate TSH secretion].
    Zass R; Steindor U; Wendel U
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):100-2. PubMed ID: 7681522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
    Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
    J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,5,3'-Triiodothyroacetic acid minimizes the pituitary thyrotrophin secretion in patients on levo-thyroxine therapy after ablative therapy for differentiated thyroid carcinoma.
    Mueller-Gaertner HW; Schneider C
    Clin Endocrinol (Oxf); 1988 Apr; 28(4):345-51. PubMed ID: 3142712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy.
    Torre P; Bertoli M; Di Giovanni S; Scommegna S; Conte C; Novelli G; Cianfarani S
    J Endocrinol Invest; 2005; 28(7):657-62. PubMed ID: 16218051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance to thyroid hormones].
    Jiskra J; Límanová Z
    Cas Lek Cesk; 2014; 153(3):137-41. PubMed ID: 24968291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.